Maxillent

Company Overview

Snapshot

Founded in September 2008 by Hadar Better, Maxillent operated with 1–10 employees. The company developed a minimally invasive sinus lift system and achieved its first human implantations within 11 months of operations. Maxillent ceased to operate in October 2021.

Business overview

Maxillent specializes in developing the iRaise sinus lift system, a technology designed to transform the sinus lift procedure into a simpler, minimally invasive intervention. The company's core offering provides ease of use for dentists and a cost-effective solution for dental implant manufacturers. Maxillent also develops prosthetics, surgical instruments, and bone graft materials, serving the dental and medical equipment markets within the Health Tech & Life Sciences sector.

Strategic signal

In June 2013, Maxillent launched its iRaise sinus lift system in France, Belgium, and Luxembourg. This expansion into key European markets demonstrated the company's early commercial traction and validation of its minimally invasive dental technology, signaling potential for broader international adoption and market penetration for its dental solutions.

Company Intelligence Q&A

What is Maxillent's primary product?

Maxillent's primary product is the iRaise sinus lift system, which is designed to make sinus lift procedures minimally invasive and simpler for dentists.

When was Maxillent founded and by whom?

Maxillent was founded in September 2008 by Hadar Better.

In which countries did Maxillent launch its iRaise system?

In June 2013, Maxillent launched its iRaise sinus lift system in France, Belgium, and Luxembourg.

What other products does Maxillent develop?

Beyond the iRaise system, Maxillent also develops prosthetics, surgical instruments, and bone graft materials.

What is the operational status of Maxillent?

Maxillent ceased to operate in October 2021.